SummaryIn 2009, the global Osteoporosis drug market was worth USD 6.8 billion,with Bisphosphonate class of drugs leading the market. In the overallBisphosphonate, ibandronate (Bonviva/Boniva; Roche) and zoledronate(Aclasta/Zometa; Novartis) accounted largest share in class, respectively,and showed an average sales growth rate of about of 20% in the past 2years.Amgen’s Denosumab is the recent entrant to the Osteoporosis treatmentmarket, following its approval from the U.S. and European Union (alsoapproved for bone loss associated with prostate cancer). Denosumab isexpected to compete directly with the Bisphosphonate drug class. However,initial uptake of Denosumab is likely to be as second-line therapy, mostly inpatients who are intolerant to Bisphosphonate. In addition to the treatmentof Osteoporosis, there is substantial potential for Denosumab for treatingbone loss in patients with cancer. Denosumab market is expected to reachUSD 3.8 billion in 2015.
ScopeThe objective of the study on “Global and China Osteoporosis Drug IndustryAnalysis and Forecast (2009 – 2015)” is to gain detailed market insights for keyOsteoporosis drugs market segments. The market is analyzed on the basis ofgrowth trends, ongoing developments, market penetration and revenue share.The report also covers the strategies followed by “Osteoporosis Drugs Market”players.Segmentation & AnalysisThe report segments and analyzes the “Osteoporosis Drugs Market” on the basisof following sub-categories:• Geographic Marketso Globalo China
Table of Contents :CHAPTER 1 EXECUTIVE SUMMARYCHAPTER 2 CHINA OSTEOPOROSIS MARKET ANALYSIS, 2009 – 20152.1 MARKET OVERVIEW2.2 50+ CHINESE POPULATION GROWTH TREND 2007 - 20502.3 CHINA POPULATION AGE STRUCTURE, 20102.4 CHINESE POPULATION WITH OSTEOPOROSIS, 2008 - 2050 (MILLION)2.5 DRIVING FACTOR ANALYSIS OF CHINA OSTEOPOROSIS MARKET2.5.1 BARGAINING POWER OF CUSTOMERS: MEDIUM/HIGH2.5.2 BARGAINING POWER OF SUPPLIERS: LOW2.5.3 THREAT OF SUBSTITUTE PRODUCTS: MEDIUM2.5.4 THREAT OF ENTRY OF NEW COMPETITORS: LOW2.5.5 INTENSITY OF COMPETITIVE RIVALRY: HIGH2.6 APPROVED OSTEOPOROSIS TREATMENT LANDSCAPE2.7 COMPETITIVE STRATEGIES……………..
More Reports:Osteoporosis Drug Market- Global And China Market Analysis, Size,Trends And Forecast (2010-2015)Excipients Market - Global Industry Analysis, Market Size, Share,Trends, Analysis, Growth And Forecast, 2012 - 2018Glass Tableware Market - Global And Egypt Industry Analysis,Market Size, Trends And Forecast, 2011 - 2017Biofuel Enzymes Market - Global Industry Size, Market Share,Trends, Analysis And Forecast, 2012 - 2018Ostomy Drainage Bags Market - Global Industry Size, Market Share,Trends, Analysis, And Forecasts, 2012 - 2018
Infertility Drugs And Devices Market - Global Industry Analysis,Size, Share And Forecast, 2010 - 2017Brazilian Animal Feed Additives Market - Industry Analysis,Market Size, Share, Growth And Forecast, 2011 - 2018Butanediol (1,4 BDO & 2,3 BDO), 1,3 Butadiene And Methyl EthylKetone (MEK) Market: Applications (THF, PU, PBT, SBR, ABS, NBREtc.), Bio-Based Alternatives, Downstream Potential, Market SizeAnd Forecast, 2010 - 2018Green Packaging Market (Recycled, Reusable & Degradable) -Global Scenario, Trends, Industry Analysis, Size, Share AndForecast, 2011 - 2018Commercial Refrigeration Equipment Market : Global IndustrySize, Market Share, Trends, Analysis And Forecast, 2012 - 2018 In Vitro Toxicity Testing Market - Global Industry Size, Share,Trends, Analysis And Forecast, 2012 - 2018
For More details about above & otherReports plz contact :LavanyaAarkstore.comContact: Marketing team Mob.No.918149852585Email: firstname.lastname@example.org ,email@example.comURL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore